These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Cooperation of Musashi-2, Numb, MDM2, and P53 in drug resistance and malignant biology of pancreatic cancer. Sheng W; Dong M; Chen C; Wang Z; Li Y; Wang K; Li Y; Zhou J FASEB J; 2017 Jun; 31(6):2429-2438. PubMed ID: 28223335 [TBL] [Abstract][Full Text] [Related]
4. Cooperation among Numb, MDM2 and p53 in the development and progression of pancreatic cancer. Sheng W; Dong M; Zhou J; Li X; Liu Q; Dong Q; Li F Cell Tissue Res; 2013 Nov; 354(2):521-32. PubMed ID: 23881403 [TBL] [Abstract][Full Text] [Related]
5. Progress in the research of p53 tumour suppressor activity controlled by Numb in triple-negative breast cancer. Xian J; Cheng Y; Qin X; Cao Y; Luo Y; Cao Y J Cell Mol Med; 2020 Jul; 24(13):7451-7459. PubMed ID: 32501652 [TBL] [Abstract][Full Text] [Related]
6. Exon 3 of the Confalonieri S; Colaluca IN; Basile A; Pece S; Di Fiore PP G3 (Bethesda); 2019 Oct; 9(10):3359-3367. PubMed ID: 31451549 [TBL] [Abstract][Full Text] [Related]
7. MDM2 protein-mediated ubiquitination of numb protein: identification of a second physiological substrate of MDM2 that employs a dual-site docking mechanism. Sczaniecka M; Gladstone K; Pettersson S; McLaren L; Huart AS; Wallace M J Biol Chem; 2012 Apr; 287(17):14052-68. PubMed ID: 22337874 [TBL] [Abstract][Full Text] [Related]
8. [The relationship and clinicopathological significance of Numb,MDM2 and p53 expression in human pancreatic cancer]. Sheng W; Dong M; Zhou J; Li X; Liu Q; Dong Q; Li F Zhonghua Wai Ke Za Zhi; 2014 Sep; 52(9):675-81. PubMed ID: 25410780 [TBL] [Abstract][Full Text] [Related]
9. The role of NUMB/NUMB isoforms in cancer stem cells. Choi HY; Seok J; Kang GH; Lim KM; Cho SG BMB Rep; 2021 Jul; 54(7):335-343. PubMed ID: 34078527 [TBL] [Abstract][Full Text] [Related]
10. Nandrolone, an anabolic steroid, stabilizes Numb protein through inhibition of mdm2 in C2C12 myoblasts. Liu XH; Yao S; Levine AC; Kirschenbaum A; Pan J; Wu Y; Qin W; Collier L; Bauman WA; Cardozo CP J Androl; 2012; 33(6):1216-23. PubMed ID: 22700758 [TBL] [Abstract][Full Text] [Related]
11. Pre-clinical validation of a selective anti-cancer stem cell therapy for Numb-deficient human breast cancers. Tosoni D; Pambianco S; Ekalle Soppo B; Zecchini S; Bertalot G; Pruneri G; Viale G; Di Fiore PP; Pece S EMBO Mol Med; 2017 May; 9(5):655-671. PubMed ID: 28298340 [TBL] [Abstract][Full Text] [Related]
12. Hepatitis B e antigen and its precursors promote the progress of hepatocellular carcinoma by interacting with NUMB and decreasing p53 activity. Liu D; Cui L; Wang Y; Yang G; He J; Hao R; Fan C; Qu M; Liu Z; Wang M; Chen L; Li H; Guo D Hepatology; 2016 Aug; 64(2):390-404. PubMed ID: 27106262 [TBL] [Abstract][Full Text] [Related]
13. Rewired Notch/p53 by Numb'ing Mdm2. Kim H; Ronai ZA J Cell Biol; 2018 Feb; 217(2):445-446. PubMed ID: 29339436 [TBL] [Abstract][Full Text] [Related]
14. The Mdm2 oncoprotein interacts with the cell fate regulator Numb. Juven-Gershon T; Shifman O; Unger T; Elkeles A; Haupt Y; Oren M Mol Cell Biol; 1998 Jul; 18(7):3974-82. PubMed ID: 9632782 [TBL] [Abstract][Full Text] [Related]
16. Alternative and aberrant messenger RNA splicing of the mdm2 oncogene in invasive breast cancer. Lukas J; Gao DQ; Keshmeshian M; Wen WH; Tsao-Wei D; Rosenberg S; Press MF Cancer Res; 2001 Apr; 61(7):3212-9. PubMed ID: 11306511 [TBL] [Abstract][Full Text] [Related]
17. Dynamic methylation of Numb by Set8 regulates its binding to p53 and apoptosis. Dhami GK; Liu H; Galka M; Voss C; Wei R; Muranko K; Kaneko T; Cregan SP; Li L; Li SS Mol Cell; 2013 May; 50(4):565-76. PubMed ID: 23706821 [TBL] [Abstract][Full Text] [Related]
19. Regulation of calcium influx and signaling pathway in cancer cells via TRPV6-Numb1 interaction. Kim SY; Yang D; Myeong J; Ha K; Kim SH; Park EJ; Kim IG; Cho NH; Lee KP; Jeon JH; So I Cell Calcium; 2013 Feb; 53(2):102-11. PubMed ID: 23140583 [TBL] [Abstract][Full Text] [Related]